# Gastrografin

NDC: 0270-0445
Generic name: diatrizoate meglumine and diatrizoate sodium
Labeler / Manufacturer: Bracco Diagnostics Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: LIQUID
Routes: ORAL, RECTAL
Marketing started: 19580226

FDA application: NDA011245

## Active ingredients

- DIATRIZOATE MEGLUMINE: 660 mg/mL
- DIATRIZOATE SODIUM: 100 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0270-0445"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0270-0445
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8c2340e4-2b42-45dc-8fac-9960e8172547